Location: Napa We’re looking for a world-class pain physician to join our team in the heart of wine country. Once in a lifetime opportunity to practice in a setting that […]
Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain […]
Neurovations Awarded 6.9 million-Dollar Grant for Groundbreaking Educational Pain Research Program
Xalud Therapeutics’ Lead Candidate, XT-150, Achieves Multiple Clinical Milestones in Pathologic Inflammation and Neuroimmunology Therapeutic Areas
Completion of enrollment for the Phase 2b study in osteoarthritis of the knee Clinical data presented at OARSI provides support for osteoarthritis program First patient dosed in the Phase 1/2a […]
Dr. Ramchandani talks about Aspirin, acetaminophen, diclofenac, ibuprofen and naproxen. More information about these medications and some history behind them.
Dr Grigsby, CEO and Founder of Neurovations, explains what Arthritis is and isn’t. There are many ways to treat chronic pain associated with arthritis. Dr. Eric Grigsby, MD, MBA has […]
Dr Grigsby, CEO and Founder on Neurovations, explains what Fibromyalgia is and isnt’
Dr. Ramchandani discusses the difference between a variant and a mutation, the efficacy of the COVID-19 vaccine on these variants, and COVID-19 as well as what COVID-19 long haulers experience. […]
“Your Health with Dr. Eric Grigsby” is brought to you by Neurovations, a patient care and innovations company, providing the best care for every patient, every day. So many remain undiagnosed […]
The Need for Research
Covid Testing is Still Important
Dr. Ramchandani discusses the history of CRPS, and ways to treat CRPS.
CEO and Founder Dr. Eric Grigsby focuses on what chronic pain really means.